Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 95

1.

Pharmacokinetic profile in late pregnancy and cord blood concentration of tipranavir and enfuvirtide.

Weizsaecker K, Kurowski M, Hoffmeister B, Schürmann D, Feiterna-Sperling C.

Int J STD AIDS. 2011 May;22(5):294-5. doi: 10.1258/ijsa.2009.009166.

PMID:
21571982
[PubMed - indexed for MEDLINE]
2.

Switch from enfuvirtide to raltegravir lowers plasma concentrations of darunavir and tipranavir: a pharmacokinetic substudy of the EASIER-ANRS 138 trial.

Goldwirt L, Braun J, de Castro N, Charreau I, Barrail-Tran A, Delaugerre C, Raffi F, Lascoux-Combe C, Aboulker JP, Taburet AM, Molina JM.

Antimicrob Agents Chemother. 2011 Jul;55(7):3613-5. doi: 10.1128/AAC.01827-10. Epub 2011 May 16.

PMID:
21576452
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Unexpected drug-drug interaction between tipranavir/ritonavir and enfuvirtide.

González de Requena D, Calcagno A, Bonora S, Ladetto L, D'Avolio A, Sciandra M, Siccardi M, Bargiacchi O, Sinicco A, Di Perri G.

AIDS. 2006 Oct 3;20(15):1977-9.

PMID:
16988521
[PubMed - indexed for MEDLINE]
4.

Low trough levels of tipranavir in a combination antiretroviral therapy of tipranavir/ritonavir and tenofovir require therapeutic drug monitoring.

Langmann P, Winzer R, Schirmer D, Heinz W, Leyh M, Guhl C, Weissbrich B, Klinker H.

Eur J Med Res. 2008 Oct 27;13(10):469-71.

PMID:
19008174
[PubMed - indexed for MEDLINE]
5.

Tipranavir: a review of its use in the management of HIV infection.

Orman JS, Perry CM.

Drugs. 2008;68(10):1435-63. Review.

PMID:
18578560
[PubMed - indexed for MEDLINE]
6.

Prevention of mother-to-child transmission of multi-drug resistant HIV-1 using maternal therapy with both enfuvirtide and tipranavir.

Wensing AM, Boucher CA, van Kasteren M, van Dijken PJ, Geelen SP, Juttmann JR.

AIDS. 2006 Jun 26;20(10):1465-7. No abstract available.

PMID:
16791028
[PubMed - indexed for MEDLINE]
7.

Combined tipranavir and enfuvirtide use associated with higher plasma tipranavir concentrations but not with increased hepatotoxicity: sub-analysis from RESIST.

Raffi F, Battegay M, Rusconi S, Opravil M, Blick G, Steigbigel RT, Kraft M, Neubacher D, Sabo JP.

AIDS. 2007 Sep 12;21(14):1977-80. Erratum in: AIDS. 2008 Aug 20;22(13):i.

PMID:
17721109
[PubMed - indexed for MEDLINE]
8.

Pharmacokinetics of plasma enfuvirtide after subcutaneous administration to patients with human immunodeficiency virus: Inverse Gaussian density absorption and 2-compartment disposition.

Zhang X, Nieforth K, Lang JM, Rouzier-Panis R, Reynes J, Dorr A, Kolis S, Stiles MR, Kinchelow T, Patel IH.

Clin Pharmacol Ther. 2002 Jul;72(1):10-9.

PMID:
12152000
[PubMed - indexed for MEDLINE]
9.

Pharmacokinetic characterization of three doses of tipranavir boosted with ritonavir on highly active antiretroviral therapy in treatment-experienced HIV-1 patients.

Goebel FD, MacGregor TR, Sabo JP, Castles M, Johnson PA, Legg D, McCallister S.

HIV Clin Trials. 2010 Jan-Feb;11(1):28-38. doi: 10.1310/hct1101-28.

PMID:
20400409
[PubMed - indexed for MEDLINE]
10.

Efficacy and safety of ritonavir dose reduction based on the tipranavir inhibitory quotient in HIV-infected patients on salvage antiretroviral therapy with tipranavir/ritonavir.

Moltó J, Valle M, Santos JR, Miranda C, Cedeño S, Negredo E, Yritia M, Videla S, Clotet B.

AIDS Res Hum Retroviruses. 2010 Nov;26(11):1191-6. doi: 10.1089/aid.2009.0304. Epub 2010 Sep 23.

PMID:
20860529
[PubMed - indexed for MEDLINE]
11.

Short communication: evaluation of the effect of enfuvirtide in 11 HIV-1 vertically infected pediatric patients outside clinical trials.

Palladino C, Briz V, González-Tomé MI, León Leal JA, Navarro ML, de José MI, Ramos JT, Muñoz-Fernández MA.

AIDS Res Hum Retroviruses. 2010 Mar;26(3):301-5. doi: 10.1089/aid.2009.0151.

PMID:
20334565
[PubMed - indexed for MEDLINE]
12.

Enfuvirtide prescription at the end of pregnancy to a multi-treated HIV-infected woman with virological breakthrough.

Meyohas MC, Lacombe K, Carbonne B, Morand-Joubert L, Girard PM.

AIDS. 2004 Sep 24;18(14):1966-8. No abstract available.

PMID:
15353987
[PubMed - indexed for MEDLINE]
13.
15.

Pharmacokinetic and pharmacodynamic determinants of early virological response to enfuvirtide-based regimens in HIV-positive patients.

de Requena DG, Bonora S, Castagna A, Hasson H, Marucco DA, D'Avolio A, Sciandra M, Trentini L, Calcagno A, Lazzarin A, Di Perri G.

J Antimicrob Chemother. 2008 Aug;62(2):384-7. doi: 10.1093/jac/dkn192. Epub 2008 May 16.

PMID:
18487231
[PubMed - indexed for MEDLINE]
Free Article
16.

Efficacy and safety of a salvage regimen based on tipranavir, enfuvirtide and three nucleoside analogues in HIV1 infected patients with clinical progression: 96-week evaluation.

Sozio F, Polilli E, D'Annunzio M, Falconi L, Di Masi F, Tontodonati M, Cosentino L, Consorte A, Di Giammartino D, Parruti G.

Infez Med. 2009 Dec;17(4):228-35.

PMID:
20046103
[PubMed - indexed for MEDLINE]
Free Article
17.

Association between tipranavir plasma levels and virological response in HIV-infected patients.

Morello J, Gascó PG, Rodriguez-Novoa S, de Mendoza C, Blanco F, Gonzalez-Pardo G, Sanz B, Jimenez-Nacher I, Soriano V.

AIDS Res Hum Retroviruses. 2008 Mar;24(3):389-91. doi: 10.1089/aid.2007.0225.

PMID:
18373431
[PubMed - indexed for MEDLINE]
18.

Successful prevention of multidrug resistant HIV mother-to-child transmission with enfuvirtide use in late pregnancy.

Madeddu G, Calia GM, Campus ML, Lovigu C, Mannazzu M, Olmeo P, Mela MG, Mura MS.

Int J STD AIDS. 2008 Sep;19(9):644-5. doi: 10.1258/ijsa.2008.008100.

PMID:
18725561
[PubMed - indexed for MEDLINE]
19.

[Desensitization to tipranavir caused by toxicodermia].

Martínez Castro B, Ferrando Piqueres R, Martínez García M, Soler Company E.

Farm Hosp. 2009 Nov-Dec;33(6):340-2. Spanish. No abstract available.

PMID:
20038397
[PubMed - indexed for MEDLINE]
20.

[Role of the new molecules in antiretroviral therapy. Position of raltegravir].

Arribas JR.

Enferm Infecc Microbiol Clin. 2008 Nov;26 Suppl 12:53-9. Review. Spanish.

PMID:
19572427
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk